Provided by Tiger Trade Technology Pte. Ltd.

Amphastar Pharmaceuticals

23.04
+0.11000.48%
Volume:351.60K
Turnover:8.05M
Market Cap:980.07M
PE:13.66
High:23.07
Open:22.84
Low:22.57
Close:22.93
52wk High:29.52
52wk Low:16.65
Shares:42.54M
Float Shares:30.52M
Volume Ratio:0.68
T/O Rate:1.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.69
EPS(LYR):2.03
ROE:10.30%
ROA:5.11%
PB:1.28
PE(LYR):11.35

Loading ...

Amphastar Senior EVP Zhou Rong Disposes of 3,187 Common Shares Worth $75,294.94

Reuters
·
Sep 04

Wells Fargo Sticks to Their Hold Rating for Amphastar Pharmaceuticals (AMPH)

TIPRANKS
·
Sep 02

Amphastar CFO Peters, EVP Marrs Present at Wells Fargo Healthcare Conference

Reuters
·
Sep 01

Amphastar Pharmaceuticals Earnings Call Balances Growth And Risk

TIPRANKS
·
Aug 21

Amphastar Pharmaceuticals is Maintained at Equal-Weight by Barclays

Dow Jones
·
Aug 19

Barclays Adjusts Price Target on Amphastar Pharmaceuticals to $23 From $20, Maintains Equalweight Rating

MT Newswires Live
·
Aug 18

Amphastar price target raised to $23 from $20 at Barclays

TIPRANKS
·
Aug 18

Amphastar CFO William J. Peters Melepas Saham Biasa Senilai $183.826,4

Reuters
·
Aug 12

Amphastar Pharmaceuticals Price Target Raised to $20.00/Share from $19.00 by Wells Fargo

Dow Jones
·
Aug 07

Amphastar Pharmaceuticals, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Amphastar Q2 GAAP Net Income Slips 2.2% to $30.35 Million; Revenue Rises 5.4% to $183.9 Million

Reuters
·
Aug 07

Amphastar Q2 2026 Earnings: New Products Lift Revenue and Gross Margin

TradingKey
·
Aug 07

Amphastar Pharmaceuticals Q2 EPS USD 0.67

Reuters
·
Aug 07

Amphastar Pharmaceuticals Updates Financial Calendar with Upcoming Q2 Earnings Release, Conference Call

Reuters
·
Jul 29

Amphastar Pharmaceuticals (AMPH) Gets a Hold from J.P. Morgan

TIPRANKS
·
Jul 23

Amphastar Names Anthony Pierce to Board as Director Expands to 11 Seats

Reuters
·
Jul 13

Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Amphastar Pharmaceuticals (AMPH) and COMPASS Pathways (CMPS)

TIPRANKS
·
Jul 09

Amphastar Pharmaceuticals - FDA Warning Letter Cites Cgmp Violations at Ims Facility - SEC Filing

THOMSON REUTERS
·
Jul 08

Amphastar Pharmaceuticals - Warning Letter Does not Require Co's Unit to Cease or Restrict Products or Recall - SEC Filing

THOMSON REUTERS
·
Jul 08

Amphastar Unit IMS Gets FDA Warning Letter for South El Monte Drug Plant

Reuters
·
Jul 08